Posted on 10/29/2021 9:10:03 AM PDT by Enlightened1
After the government authorized the use of Ivermectin for COVID-19 patients and its population, the number of cases have significantly plummeted since July.
he data above proves that Ivermectin played a role in the steep decline of COVID-19 cases. This is obvious despite the claim from fact-checker website below that there is “no evidence that the fall in COVID-19 cases in Indonesia is linked to the use of Ivermectin.”
Here’s the excerpt from Health Feedback:
Clinical trials didn’t show a clear benefit of ivermectin in reducing COVID-19 severity, hospitalization rate, or mortality. Epidemiological evidence also doesn’t indicate that ivermectin helped curb the number of COVID-19 cases and deaths in Indonesia or in other countries. However, these countries implemented other measures that have proven effective in limiting the spread of the virus, including vaccination and restrictions, which likely contributed to the decline in COVID-19 cases.
Simply because two events coincide in time doesn’t necessarily mean that one caused the other. Firstly, ivermectin endorsement doesn’t tell us whether the Indonesian population actually used ivermectin more than populations in other countries.
Secondly, even if the use of ivermectin did increase following the recommendation, we still can’t assess whether the drop in COVID-19 cases in Indonesia was due to the use of ivermectin or to other factors. Epidemiological data from countries that recommended ivermectin, such as India and Peru, doesn’t indicate that promoting the drug reduced the spread of the disease or its death toll. Both countries experienced multiple COVID-19 waves with high mortality throughout 2020 and 2021, and both withdrew ivermectin recommendations in 2021.
How do these fact-checkers explain the significant drop of cases in countries where Ivermectin is widely used like India, Indonesia, Namibia, and other countries?
While countries with high vaccination rates continue to experience major outbreaks of COVID-19, like Singapore, Ireland , the UK, Israel and many more.
The massive drop of COVID-19 cases started after the government of Indonesia granted the emergency use of Ivermectin to COVID-19 patients. The country had a very low vaccination rate at the time with only 7.5% fully vaccinated in July.
But that’s horse paste y’all...
Like India, Indonesia doesn’t have the resources to PROPERLY manage and treat Covid.
Therefore they are forced to cheaply eradicate it and get on with their lives.
Thankfully, we in the West have more options.
If they are able to eradicate it by a cheap and totally effective method/drug, why would we even consider other options?
Why to satisfy the pharmas and make them rich ..... er!
With Herr Fauci still making money I’m sure we will never see cheap meds.
The lying Aholes “reporting” this are conflating. Several issues:
1) testing by PCR is totally bogus. It has been months since the CDC withdrew that test because it was scientifically invalid. So, any numbers on cases are suspicious.
2) IverXX has been used extensively elsewhere and, in combination with other treatments as necessary (case by case) it does reduce symptoms and deaths.
3)Use of IverXX must be tied to deaths — not cases.
4) Ample evidence and testimony by docs that mRNA vaxes provide no protection against infection (or re-infection) and no immunity. They protect only the vaxxed, not society. So, cases will go up or down.
Yet ANOTHER ‘coincidence’ involving Ivermectin. So MANY ‘coincidences’ over the last several years. It is TRULY AMAZING!
</sarc>
“If they are able to eradicate it by a cheap and totally effective method/drug, why would we even consider other options?”
Because we can afford them! That’s why.
“But they are killing people in huge numbers, whereas, Ivermectin is not.”
Details, details...
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.
